Excise valuation and small-scale exemption hinge on related person status, brand ownership, and sustainable penalty liability.

Excise valuation requires proof of mutual interest in the business of each other before a buyer can be treated as a related person; mere shareholding, financial support, guarantees, or exclusive purchase arrangements are not enough, and the buyer's resale price cannot automatically govern assessable value. For small-scale exemption, clearances of branded goods bearing another person's trade mark are excluded from aggregate turnover when the brand belongs to that other person. Penalties under the Act and Rules depend on a sustainable underlying demand and proper attribution of liability; where those foundations fail, penalty exposure also falls away.

---

---

Issues: (i) Whether the buyer could be treated as a related person for valuation of excisable goods and whether the buyer's resale price could be adopted as the assessable value; (ii) Whether the value of clearances of two branded medicines was to be excluded while computing eligibility for small-scale exemption; (iii) Whether penalties under the Act and the Rules were sustainable.

Issue (i): Whether the buyer could be treated as a related person for valuation of excisable goods and whether the buyer's resale price could be adopted as the assessable value.

Analysis: The definition of related person requires a direct or indirect interest in the business of each other. Mere shareholding by the buyer, financial assistance, guarantees, or the fact that the entire production was purchased by that buyer, without proof of reciprocal business interest or extra-commercial consideration, is insufficient. The arrangement remained one of sale on principal-to-principal basis, and the buyer's resale price could not by itself govern assessable value.

Conclusion: The buyer was not a related person, and the buyer's resale price could not be adopted as the assessable value. This issue is decided in favour of the assessee.

Issue (ii): Whether the value of clearances of two branded medicines was to be excluded while computing eligibility for small-scale exemption.

Analysis: For the exemption computation, branded goods bearing the trade name of another person are not to be included where the brand belongs to that other person. On the facts, two medicines were registered under the trade and merchandise marks of the buyer, while the remaining medicines stood in the assessee's name. The value attributable to the two buyer-owned branded medicines was therefore liable to be excluded from the aggregate clearances for exemption purposes.

Conclusion: The value of the two medicines branded in the buyer's name was to be excluded while computing aggregate clearances. This issue is decided in favour of the assessee.

Issue (iii): Whether penalties under the Act and the Rules were sustainable.

Analysis: Once the valuation basis adopted by the department failed and the brand-name exclusion issue was resolved in the assessee's favour, the foundation for penalty did not survive. The role of the individual noticees was also not adequately established for penalty under the Rules.

Conclusion: The penalties were not sustainable and were set aside. This issue is decided in favour of the assessee.

Final Conclusion: The common order granted relief to the assessee on valuation, exemption computation, and penalties, and the connected appeals stood disposed of accordingly.

Ratio Decidendi: Related person status under excise valuation requires mutuality of interest in the business of each other, and absent proof of such reciprocal interest or extra-commercial consideration, the purchaser's resale price cannot be used as assessable value.

---